Skip to content
Brand AI

Eureka Therapeutics

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2020

    JW Therapeutics announces acquisition of Syracuse Biopharma

    JW Therapeutics announced its acquisition of Syracuse Biopharma (Hong Kong) Limited. The acquisition includes a license for Eureka Therapeutics’ ARTEMIS antibody TCR and solid tumor technology for exclusive use in China and the ASEAN countries; transaction terms were not disclosed.

    Source